DHR Danaher Corporation Common Stock
Danaher Corporation Common Stock Hakkında Wikipedia'dan şirket genel bakışı
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing.
Devamını oku
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology (28% of 2024 revenues), which develops products for the development of therapeutics; life sciences (31% of 2024 revenues), which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics (41% of 2024 revenues), which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing.
The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000.
History
Early years
The company's origins go back to DMG, Inc., a Massachusetts real estate investment trust organized in 1969. In 1978, DMG, Inc. was reorganized as a Florida corporation and changed its name to Diversified Mortgage Investors, Inc. In 1983, the Stephen M. Rales and Mitchell P. Rales invested in the company, which at that time was invested in retirement home developments, they then replaced the existing management in a bitter proxy battle. The name came from a river in Montana.
In 1984, the company adopted the name Danaher and reincorporated under the Delaware General Corporation Law.
In 1985, the Rales brothers offered $400 million in a hostile bid for Scott Fetzer Company but lost out to Berkshire Hathaway.
In June 1986, Danaher acquired Chicago Pneumatic in a hostile takeover, offering $60.8 million for the 32% of the company not already owned. The company had merged in July 1984 with a sister company, the Jacobs Manufacturing Co., and had purchased Matco Tools in April 1981.
In June 1987, Danaher sold Chicago Pneumatic while retaining Jacobs, including its Matco Tools Division. Jacobs' name was changed to Matco Tools Corp. In November 1991, the other divisions within Jacobs were established as separate operating companies. In January 1993, Danaher formed NMTC, Inc., which acquired a substantial portion of the assets of MTC, including the existing distributorship agreements of MTC.
In 1986, Danaher added Qualitrol to its instrumentation unit, including Gilbarco Veeder-Root's underground fuel storage sensors, Dynapar's motion sensors, and pressure measurement and temperature measurement instruments used on the electrical transformer industry.
1990–2000
In 1990, Danaher acquired Easco Hand Tools Inc. Danaher was selected as exclusive supplier of hand tools for Sears. In 1994, Danaher acquired Armstrong Tools, the makers of tool brands Armstrong, Allen, and others.
In 1995, Danaher acquired Hengstler GmbH, a manufacturer of counters, printers, relays, and high-precision rotational sensors. Hengstler was Danaher's first acquisition headquartered outside the United States.
In 1999, the company acquired Hach Company, involved in water and wastewater—and analytics, for $325 million.
2001–2010
In 2000, H. Lawrence Culp Jr. was named CEO of Danaher; he had joined the company in 1990.
Danaher acquired Trojan Technologies, an environmental engineering firm, in 2004.
Danaher also acquired UK-based West Instruments, which provides control and measurement instrumentation and services for the global industrial and process markets.
Danaher announced its agreement to acquire the Gendex division from DENTSPLY International on
December 11, 2003, with the acquisition closing in early 2004, integrating this dental imaging company into Danaher's growing dental portfolio.
PMA, a German manufacturer of control and measurement instrumentation, was acquired in April 2005.
In July 2005, Danaher acquired Leica Microsystems, which manufactures products for applications requiring microscopic imaging, measurement and analysis and offers management systems for biotechnology and medicine, as well as the science of raw materials and industrial quality assurance.
In early 2007, Danaher acquired Vision Systems, which manufactures and markets automated instruments, antibodies and biochemical reagents for biopsy-based detection of cancer and infectious diseases, for $520 million.
In July 2007, Danaher acquired ChemTreat.
In November 2007, Danaher purchased Tektronix for US$2.85 billion.
In 2009, Danaher acquired the Analytical Technologies business unit of MDS, including a 50% interest in AB SCIEX, for US$650 million. In February 2010, Danaher acquired the remaining 50% ownership position in AB SCIEX from Life Technologies for US$450 million.
2011–2020
In 2011, Danaher acquired Beckman Coulter, which was divided into a diagnostics segment and a life sciences segment.
In January 2012, Danaher sold Accu-sort to Datalogic.
In December 2012, Danaher acquired Navman Wireless, a provider of on-demand fleet and asset management technology.
In February 2013, Danaher and Cooper Industries sold their joint venture, Apex Tool Group, to Bain Capital for $1.6 billion.
In September 2014, Danaher acquired Nobel Biocare for $2.2 billion.
Effective March 1, 2015, H. Lawrence Culp Jr. resigned as CEO of Danaher.
In July 2015, Danaher combined its communications unit with NetScout Systems.
In August 2015, Danaher acquired Pall Corporation for $13.8 billion.
In June 2016, Danaher completed the corporate spin-off of Fortive, which included Matco and AMMCO-COATS. In September of the same year, the company announced it would acquire Cepheid for $4 billion including debt.
In October 2016, Danaher acquired Phenomenex for $700 million to expand in life sciences.
In October 2017, Danaher announced the acquisition of scientific informatics company ID Business Solutions Ltd. (IDBS). IDBS became part of Danaher's Life Sciences platform.
In March 2018, Danaher acquired Integrated DNA Technologies for an estimated $1.9 billion.
In July 2018, Danaher announced its intention to spin off its Dental segment into a public company, later named Envista Holdings Corporation. The corporate spin-off was completed in December 2019.
In March 2020, Integrated DNA Technologies, a subsidiary of the company, manufactured components for COVID-19 testing.
In March 2020, Danaher acquired the biopharma business of General Electric, a global provider of technologies and services related to the development, manufacture, and delivery of vaccines, diagnostics, and therapeutics to customers in organizations including academia, biotechnology, and drug manufacturing, for $21.4 billion and was rebranded as Cytiva. The GE deal raised monopoly concerns. The Federal Trade Commission conditionally approved the deal on the grounds that Danaher sold some biotechnology assets. In a second deal, Danaher's biomolecular characterization, chromatography hardware and resins, microcarriers and particle validation standards businesses were sold to Sartorius AG for approximately $825 million. The Cytiva name is derived from 'cyto' meaning 'cell' in Greek, and 'iva' a Latin suffix meaning 'doing' and 'capable of'.
Effective September 2020, Tom Joyce retired as CEO of the company; he was replaced by Executive Vice President Rainer Blair.
2021–present
In June 2021, Precision Nanosystems was acquired by Cytiva.
In August 2021, Danaher acquired Aldevron, which produces mRNA and proteins used in mRNA vaccines, for $9.6 billion in cash.
In May 2023, Pall Corporation merged with Cytiva to create a new Biotechnology Group within Danaher; at that time Cytiva employed more than 16,000 associates in over 40 countries.
Also in September 2022, Danaher announced its intention to spin off its Environmental & Applied Solutions segment; in February 2023, it was named Veralto and the corporate spin-off was completed in September 2023. The division included Aquatic Informatics, ChemTreat, Esko, Hach Company, Linx, McCrometer, OTT HydroMet, Pantone, Sea-Bird Scientific, Trojan Technologies, Videojet, XOS, and X-Rite.
In December 2023, Danaher acquired Abcam for approximately $5.7 billion.
In June 2024, the Food and Drug Administration granted marketing approval to Danaher's Cepheid unit for a rapid test for hepatitis C. Using a blood sample from a fingertip, the rapid test detects the virus's RNA and delivers results in less than roughly an hour, as opposed to requiring a sample to be sent to a lab.
In August 2024, the company acquired GeneData. In February 2026, Danaher announced it would acquire Masimo for $10 billion.
Divisions
Life sciences
Abcam
Beckman Coulter - Life Sciences
Cytiva
Integrated DNA Technologies
Leica Microsystems
Molecular Devices
Pall Corporation
SCIEX
Diagnostics
Beckman Coulter - Diagnostics
Cepheid
Leica Biosystems
Radiometer
Kaynak: Wikipedia (İngilizce), CC BY-SA 4.0 · Wikipedia'da Görüntüle ↗
DHR Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
DHR Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Temettüler Temettü verimi, ödeme oranı, temettü geçmişi, 5 Yıllık CAGR
| Ex-tarihi | Miktar |
|---|---|
| 26 Haziran 2026 | $0,4000 |
| 27 Mart 2026 | $0,4000 |
| 26 Aralık 2025 | $0,3200 |
| 26 Eylül 2025 | $0,3200 |
| 27 Haziran 2025 | $0,3200 |
| 28 Mart 2025 | $0,3200 |
| 27 Aralık 2024 | $0,2700 |
| 27 Eylül 2024 | $0,2700 |
| 28 Haziran 2024 | $0,2700 |
| 27 Mart 2024 | $0,2700 |
| 28 Aralık 2023 | $0,2400 |
| 11 Ekim 2023 | $0,2700 |
| 29 Haziran 2023 | $0,2394 |
| 30 Mart 2023 | $0,2394 |
| 29 Aralık 2022 | $0,2216 |
| 29 Eylül 2022 | $0,2216 |
| 23 Haziran 2022 | $0,2216 |
| 24 Mart 2022 | $0,2216 |
| 29 Aralık 2021 | $0,1862 |
| 29 Eylül 2021 | $0,1862 |
DHR Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
- Güçlü Al 12 37,5%
- Al 15 46,9%
- Tut 5 15,6%
- Sat 0 0,0%
- Güçlü Sat 0 0,0%
12 Aylık Fiyat Hedefi
23 analist · 2026-08-14Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 30 Haziran 2026 | $1.94 | $1.85 | 0.09% |
| 31 Mart 2026 | $2.06 | $1.96 | 0.10% |
| 31 Aralık 2025 | $2.23 | $2.17 | 0.06% |
| 30 Eylül 2025 | $1.89 | $1.74 | 0.15% |
| 30 Haziran 2025 | $1.80 | $1.66 | 0.14% |
| 31 Mart 2025 | $1.88 | $1.66 | 0.22% |
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| DHR | $161.82B | 45.3 | 2.9% | 14.7% | 7.1% | 59.1% |
| TMO | $257.86B | 32.7 | 3.9% | 15.0% | 13.0% | — |
| A | $41.43B | 32.0 | 6.7% | 18.8% | 20.6% | — |
| IQV | $38.23B | 28.8 | 5.9% | 8.3% | 21.6% | — |
| WAT | $22.62B | 35.3 | 7.0% | 20.3% | 27.2% | — |
| ILMN | $20.65B | 24.8 | -0.66% | 19.6% | 34.1% | 66.1% |
| MTD | $28.38B | 33.2 | 4.0% | 21.6% | -615.5% | 59.4% |
| WST | $19.81B | 40.5 | 6.2% | 16.1% | 16.2% | 35.9% |
| MEDP | $15.93B | 36.8 | 20.0% | 17.8% | 142.9% | — |
| TEM | — | -41.9 | 83.4% | -19.3% | -61.2% | — |
| CRL | $10.02B | -70.0 | -0.85% | -3.6% | -4.4% | — |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 17
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $24.57B | $23.88B | $23.89B | $26.64B | $24.80B | $22.28B | $17.91B | $17.05B | $15.52B | $16.88B | $14.43B | $12.87B | |
| Cost of Revenue | $10.04B | $9.67B | $9.86B | $10.46B | $9.56B | $9.81B | $7.93B | $7.54B | $6.95B | $7.55B | $6.66B | $6.02B | |
| Gross Profit | $14.52B | $14.21B | $14.03B | $16.19B | $15.24B | $12.47B | $9.98B | $9.51B | $8.57B | $9.33B | $7.77B | $6.85B | |
| R&D Expense | $1.60B | $1.58B | $1.50B | $1.53B | $1.50B | $1.35B | $1.13B | $1.06B | $956M | $975M | $861M | $769M | |
| SG&A Expense | $8.23B | $7.76B | $7.33B | $7.12B | $6.82B | $6.90B | $5.59B | $5.39B | $5.04B | $5.62B | $4.75B | $4.04B | |
| Operating Income | $4.69B | $4.86B | $5.20B | $7.54B | $6.38B | $4.23B | $3.27B | $3.06B | $2.57B | $2.74B | $2.16B | $2.04B | |
| Interest Expense | · | · | $286M | $204M | $231M | $275M | $108M | $137M | $140M | $184M | $140M | $95M | |
| Interest Income | $30M | $117M | $303M | $41M | $11M | $71M | $139M | $9M | $8M | $200.0K | $5M | $13M | |
| Other Non-op | $-222M | $-56M | $-175M | $-227M | $450M | $494M | $12M | $35M | · | · | · | · | |
| Pretax Income | $4.23B | $4.65B | $5.04B | $7.15B | $6.51B | $4.50B | $3.31B | $2.96B | $2.54B | $2.61B | $2.04B | $2.09B | |
| Income Tax | $633M | $747M | $823M | $818M | $1.06B | $849M | $873M | $556M | $371M | $458M | $293M | $448M | |
| Net Income | $3.61B | $3.90B | $4.76B | $7.21B | $6.43B | $3.65B | $3.01B | $2.65B | $2.49B | $2.55B | $3.36B | $2.60B | |
| EPS (Basic) | $5.07 | $5.33 | $6.44 | $9.80 | $8.77 | $4.97 | $4.11 | $3.78 | $3.58 | $3.69 | $4.81 | $3.70 | |
| EPS (Diluted) | $5.05 | $5.29 | $6.38 | $9.66 | $8.61 | $4.89 | $4.05 | $3.74 | $3.53 | $3.65 | $4.74 | $3.63 | |
| Shares (Basic) | 712,700,000 | 731,000,000 | 736,500,000 | 725,100,000 | 714,600,000 | 706,200,000 | 715,000,000 | 700,600,000 | 695,800,000 | 691,200,000 | 698,100,000 | 702,200,000 | |
| Shares (Diluted) | 716,100,000 | 737,200,000 | 743,100,000 | 737,100,000 | 736,800,000 | 718,700,000 | 725,500,000 | 710,200,000 | 706,100,000 | 699,800,000 | 708,500,000 | 716,100,000 | |
| EBITDA | $4.69B | $4.86B | $7.37B | $10.91B | $9.63B | $6.01B | $4.46B | $4.71B | $4.26B | $3.88B | $4.52B | $4.37B |
Bilanço 26
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | · | · | · | · | · | $19.91B | $788M | $630M | $964M | $791M | $3.01B | |
| Receivables | $3.91B | $3.54B | $3.92B | $4.10B | $4.63B | $4.04B | $3.19B | $3.03B | $3.52B | $3.19B | $2.99B | $3.45B | |
| Inventory | $2.49B | $2.33B | $2.59B | $2.77B | $2.77B | $2.29B | $1.63B | $1.63B | $1.84B | $1.71B | $1.57B | $1.78B | |
| Prepaid Expense | $1.74B | $1.55B | $1.56B | $1.74B | $1.66B | $1.43B | $865M | $858M | $857M | $806M | $890M | $953M | |
| Current Assets | $12.76B | $9.50B | $13.94B | $15.88B | $11.65B | $13.80B | $25.60B | $7.09B | $6.85B | $6.67B | $7.84B | $9.43B | |
| PP&E (Net) | $5.53B | $4.99B | $4.55B | $3.71B | $3.53B | $3.26B | $2.30B | $2.25B | $2.22B | $2.35B | $2.30B | $1.67B | |
| PP&E (Gross) | $10.30B | $9.09B | $8.38B | $7.14B | $7.25B | $6.44B | $5.06B | $4.70B | $4.97B | $4.32B | $3.99B | $4.71B | |
| Accum. Depreciation | $4.77B | $4.10B | $3.83B | $3.43B | $3.46B | $3.18B | $2.76B | $2.45B | $2.52B | $1.96B | $1.69B | $2.54B | |
| Goodwill | $43.15B | $40.50B | $41.61B | $37.28B | $38.68B | $35.42B | $22.71B | $22.58B | $21.77B | $23.83B | $21.01B | $11.58B | |
| Intangibles | $17.82B | $18.57B | $20.75B | $19.82B | $22.84B | $21.28B | $9.75B | $10.28B | $11.67B | $11.82B | $10.55B | $7.06B | |
| Other Non-current Assets | $4.21B | $3.99B | $3.64B | $4.16B | $3.72B | $2.40B | $1.72B | $571M | $538M | $631M | $845M | $1.02B | |
| Total Assets | $83.46B | $77.54B | $84.49B | $84.35B | $83.18B | $76.16B | $62.08B | $47.83B | $46.65B | $45.30B | $48.22B | $36.99B | |
| Accrued Liabilities | $4.96B | $4.54B | $4.81B | $4.82B | $5.56B | $5.34B | $3.21B | $2.69B | $3.09B | $2.79B | $2.61B | $3.19B | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | · | $765M | |
| Current Liabilities | $6.81B | $6.80B | $8.27B | $8.39B | $8.14B | $7.40B | $4.93B | $4.84B | $4.79B | $6.87B | $6.17B | $5.40B | |
| Capital Leases | $1.08B | $968M | $954M | $772M | $889M | $785M | $639M | $0 | · | · | · | · | |
| Other Non-current Liabilities | $5.70B | $5.69B | $6.02B | $6.50B | $7.70B | $7.79B | $5.35B | $4.70B | $5.16B | $5.67B | $5.75B | $4.58B | |
| Long-term Debt | $18.42B | $16.00B | $18.40B | $19.68B | $22.18B | $21.20B | $21.73B | $9.74B | $10.52B | $12.27B | $12.87B | $3.47B | |
| Total Debt | $18.42B | $15.50B | $16.71B | $19.09B | $22.17B | $21.19B | $21.52B | $9.69B | $10.33B | $9.67B | $12.03B | $4.17B | |
| Common Stock | $9M | $9M | $9M | $9M | $9M | $9M | $8M | $8M | $8M | $8M | $8M | $8M | |
| Retained Earnings | $46.89B | $44.19B | $41.07B | $39.20B | $32.83B | $27.16B | $24.17B | $25.16B | $22.81B | $20.70B | $21.01B | $20.32B | |
| Treasury Stock | $11.35B | $8.16B | $2.02B | · | · | · | · | · | · | · | · | · | |
| AOCI | $-207M | $-3.22B | $-1.75B | $-2.87B | $-1.03B | $-368M | $-3.07B | $-2.79B | $-2.15B | $-3.02B | $-2.31B | $-1.43B | |
| Stockholders' Equity | $52.53B | $49.54B | $53.49B | $50.08B | $45.17B | $39.77B | $30.27B | $28.21B | $26.36B | $23.00B | $23.69B | $23.38B | |
| Liabilities + Equity | $83.46B | $77.54B | $84.49B | $84.35B | $83.18B | $76.16B | $62.08B | $47.83B | $46.65B | $45.30B | $48.22B | $36.99B | |
| Shares Outstanding | 706,900,000 | 719,100,000 | 739,200,000 | 728,300,000 | 715,000,000 | 711,000,000 | 695,500,000 | 701,500,000 | 696,600,000 | 692,200,000 | 686,800,000 | 704,300,000 |
Nakit Akışı 19
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | $2.17B | $2.13B | $2.06B | $1.77B | $1.19B | $1.18B | $1.12B | $1.13B | $881M | $718M | |
| Stock-based Comp | $298M | $288M | $306M | $295M | $184M | $187M | $159M | $138M | $127M | $130M | $104M | $85M | |
| Amort. of Intangibles | $1.70B | $1.63B | $1.49B | $1.43B | $1.39B | $1.14B | $625M | $616M | $579M | $583M | $397M | $269M | |
| Restructuring | · | · | · | · | · | · | · | $70M | $159M | $152M | $98M | $102M | |
| Other Non-cash | · | · | $-72M | $-1.25B | $-461M | $600M | $-405M | $-88M | $-392M | $-290M | $-746M | $100M | |
| Operating Cash Flow | $6.42B | $6.69B | $7.16B | $8.52B | $8.36B | $6.21B | $3.95B | $4.02B | $3.48B | $3.52B | $3.80B | $3.76B | |
| CapEx | $1.16B | $1.39B | $1.38B | $1.12B | $1.24B | $791M | $636M | $584M | $571M | $590M | $513M | $465M | |
| Investing Cash Flow | $-1.20B | $-1.98B | $-7.08B | $-2.23B | $-12.99B | $-21.24B | $-1.24B | $-2.95B | $-843M | $-5.24B | $-14.95B | $-3.44B | |
| Debt Issued | · | · | · | · | · | · | $12.11B | $0 | $1.78B | $3.24B | $5.68B | $0 | |
| Net Debt Issued | · | · | · | · | · | · | $10.55B | $-508M | $1.11B | $760M | $5.65B | $-415M | |
| Stock Issued | · | · | · | $0 | $0 | $1.73B | $1.44B | $0 | $0 | $164M | $249M | $133M | |
| Stock Repurchased | $3.09B | $5.98B | $0 | $0 | · | · | · | · | · | · | · | $0 | |
| Net Stock Activity | $-3.09B | $-5.98B | · | $0 | $0 | $1.73B | $1.44B | $96M | $69M | $164M | $249M | $133M | |
| Dividends Paid | $878M | $768M | $821M | $818M | $742M | $615M | $527M | $433M | $378M | $400M | $354M | $228M | |
| Financing Cash Flow | $-2.96B | $-8.38B | $-273M | $-2.57B | $1.29B | $1.01B | $16.36B | $-797M | $-3.10B | $2.04B | $9.05B | $-218M | |
| Net Change in Cash | $2.54B | $-3.79B | $-131M | $3.41B | $-3.45B | $-13.88B | $19.12B | $158M | $-333M | $173M | $-2.21B | $-110M | |
| Taxes Paid | $1.20B | $1.30B | $1.80B | $1.80B | $1.70B | · | · | · | · | · | · | · | |
| Free Cash Flow | $5.26B | $5.30B | $5.78B | $7.37B | $7.06B | $5.42B | $3.32B | $3.37B | $2.86B | $2.93B | $3.17B | $3.16B | |
| Levered FCF | · | · | $5.54B | $7.18B | $6.87B | $5.19B | $3.24B | $3.24B | $2.72B | $2.78B | $3.04B | $3.07B |
Kârlılık 8
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 59.1% | 59.5% | 58.7% | 60.2% | 61.0% | 56.0% | 55.7% | 55.8% | 55.6% | 55.3% | 52.3% | 52.4% | |
| Operating Margin | 19.1% | 20.4% | 21.8% | 27.6% | 25.4% | 19.0% | 18.2% | 17.1% | 16.5% | 16.3% | 16.9% | 17.2% | |
| Net Margin | 14.7% | 16.3% | 19.9% | 22.9% | 21.8% | 16.4% | 16.8% | 13.3% | 13.6% | 15.1% | 16.3% | 13.1% | |
| Pretax Margin | 17.2% | 19.5% | 21.1% | 26.4% | 25.8% | 20.2% | 18.4% | 16.6% | 16.0% | 15.5% | 16.2% | 17.5% | |
| EBITDA Margin | 19.1% | 20.4% | 30.8% | 34.7% | 32.7% | 27.0% | 24.9% | 23.7% | 23.2% | 23.0% | 22.0% | 21.9% | |
| ROA | 4.5% | 4.8% | 5.6% | 8.6% | 8.1% | 5.3% | 5.5% | 5.6% | 5.4% | 5.5% | 7.9% | 7.2% | |
| ROE | 7.1% | 7.6% | 9.2% | 15.1% | 15.2% | 10.4% | 10.3% | 9.7% | 10.1% | 10.9% | 14.3% | 11.4% | |
| ROIC | 5.6% | 6.3% | 6.2% | 10.9% | 9.3% | 5.6% | 4.7% | 7.2% | 6.9% | 6.9% | 7.6% | 9.3% |
Likidite ve Solventlik 5
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.9 | 1.4 | 1.7 | 1.9 | 1.4 | 1.9 | 5.2 | 1.5 | 1.4 | 1.0 | 1.3 | 1.7 | |
| Quick Ratio | 0.6 | 0.5 | 0.5 | 0.6 | 0.6 | 0.5 | 4.7 | 0.9 | 0.9 | 0.6 | 0.8 | 1.2 | |
| Debt / Equity | 0.4 | 0.3 | 0.3 | 0.4 | 0.5 | 0.5 | 0.7 | 0.3 | 0.4 | 0.4 | 0.5 | 0.2 | |
| LT Debt / Equity | 0.4 | 0.3 | 0.3 | 0.4 | 0.5 | 0.5 | 0.7 | 0.3 | 0.4 | 0.4 | 0.5 | 0.1 | |
| Interest Coverage | · | · | 18.2 | 41.2 | 31.4 | 15.4 | 30.1 | 21.6 | 18.6 | 14.9 | 21.3 | 28.0 |
Verimlilik 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | 0.3 | 0.4 | 0.4 | 0.3 | 0.3 | 0.4 | 0.4 | 0.4 | 0.5 | 0.6 | |
| Inventory Turnover | 4.2 | 3.9 | 3.7 | 4.3 | 4.5 | 5.0 | 4.9 | 4.7 | 4.6 | 4.6 | 5.1 | 5.2 | |
| Receivables Turnover | 6.6 | 6.4 | 6.0 | 6.6 | 6.8 | 6.2 | 5.8 | 5.7 | 5.5 | 5.5 | 5.6 | 5.6 |
Büyüme Oranları 10
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 2.9% | -0.06% | -10.3% | 7.4% | 11.3% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -2.7% | -1.3% | 2.4% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 2.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -4.5% | -17.1% | -34.0% | 12.2% | 76.1% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -19.4% | -15.0% | 9.3% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 0.65% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -7.3% | -18.2% | -33.9% | 12.1% | 76.4% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -20.6% | -15.4% | 9.3% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -0.18% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 7.4% | · | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM) 16
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $24.57B | $23.88B | $23.89B | $26.64B | $24.80B | $22.28B | $17.91B | $17.05B | $15.52B | $16.88B | $14.43B | $12.87B | |
| Net Income TTM | $3.61B | $3.90B | $4.76B | $7.21B | $6.43B | $3.65B | $3.01B | $2.65B | $2.49B | $2.55B | $3.36B | $2.60B | |
| Market Cap | $161.82B | $165.07B | $171.01B | $171.37B | $208.55B | $140.02B | $94.63B | $64.13B | $57.32B | $47.77B | $56.55B | $53.52B | |
| Enterprise Value | · | · | · | · | · | · | $96.24B | $73.03B | $67.02B | $56.48B | $67.79B | $54.68B | |
| P/E | 45.3 | 43.4 | 36.3 | 24.4 | 33.9 | 40.3 | 33.6 | 24.4 | 23.3 | 18.9 | 17.4 | 20.9 | |
| P/S | 6.6 | 6.9 | 7.2 | 6.4 | 8.4 | 6.3 | 5.3 | 3.8 | 3.7 | 2.8 | 3.9 | 4.2 | |
| P/B | 3.1 | 3.3 | 3.2 | 3.4 | 4.6 | 3.5 | 3.1 | 2.3 | 2.2 | 2.1 | 2.4 | 2.3 | |
| P / Cash Flow | 25.2 | 24.7 | 23.9 | 20.1 | 25.0 | 22.6 | 23.9 | 15.9 | 16.5 | 13.6 | 14.9 | 14.2 | |
| P / FCF | 30.8 | 31.2 | 29.6 | 23.3 | 29.5 | 25.8 | 28.5 | 19.1 | 20.1 | 16.3 | 17.8 | 16.9 | |
| EV / EBITDA | · | · | · | · | · | · | 21.6 | 15.5 | 15.7 | 14.6 | 15.0 | 12.5 | |
| EV / FCF | · | · | · | · | · | · | 29.0 | 21.7 | 23.4 | 19.3 | 21.4 | 17.3 | |
| EV / Revenue | · | · | · | · | · | · | 5.4 | 4.3 | 4.3 | 3.3 | 4.7 | 4.2 | |
| Dividend Yield | 0.54% | 0.47% | 0.48% | 0.48% | 0.36% | 0.44% | 0.56% | 0.68% | 0.66% | 0.84% | 0.63% | 0.43% | |
| Earnings Yield | 2.2% | 2.3% | 2.8% | 4.1% | 2.9% | 2.5% | 3.0% | 4.1% | 4.3% | 5.3% | 5.8% | 4.8% | |
| Payout Ratio | 24.3% | 19.7% | 17.2% | 11.3% | 11.5% | 16.9% | 17.5% | 16.4% | 15.2% | 15.7% | 10.5% | 8.8% | |
| Annual Payout | $878M | $768M | $821M | $818M | $742M | $615M | $527M | $433M | $378M | $400M | $354M | $228M |
Gelir Tablosu 17
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.26B | $5.95B | $6.84B | $6.05B | $5.94B | $5.74B | $6.54B | $5.80B | $5.74B | $5.80B | $6.41B | $5.62B | $5.91B | $5.95B | $3.54B | $6.46B | |
| Cost of Revenue | $2.65B | $2.36B | $2.87B | $2.53B | $2.41B | $2.23B | $2.65B | $2.40B | $2.31B | $2.31B | $2.63B | $2.35B | $2.59B | $2.29B | $1.36B | $3.08B | |
| Gross Profit | $3.61B | $3.59B | $3.97B | $3.52B | $3.52B | $3.51B | $3.89B | $3.40B | $3.43B | $3.49B | $3.78B | $3.27B | $3.32B | $3.66B | $2.18B | $3.89B | |
| R&D Expense | $412M | $387M | $438M | $378M | $403M | $379M | $442M | $383M | $391M | $368M | $407M | $362M | $361M | $373M | $236M | $420M | |
| SG&A Expense | $2.07B | $1.86B | $2.03B | $1.99B | $2.36B | $1.86B | $2.02B | $2.06B | $1.87B | $1.81B | $2.04B | $1.73B | $1.79B | $1.77B | $798M | $2.15B | |
| Operating Income | $1.13B | $1.34B | $1.50B | $1.15B | $760M | $1.27B | $1.43B | $958M | $1.17B | $1.31B | $1.34B | $1.19B | $1.16B | $1.52B | $1.14B | $1.72B | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $65M | · | $73M | $67M | $66M | · | $42M | |
| Interest Income | $61M | $27M | $13M | $3M | $8M | $6M | $14M | $4M | $39M | $60M | $117M | $79M | $59M | $48M | $29M | $9M | |
| Other Non-op | $-3M | $-73M | $-87M | $-14M | $-42M | $-79M | $-63M | $102M | $-59M | $-36M | $-137M | $-47M | $-15M | $24M | $-69M | $-51M | |
| Pretax Income | $1.08B | $1.24B | $1.37B | $1.08B | $655M | $1.13B | $1.31B | $977M | $1.08B | $1.27B | $1.23B | $1.15B | $1.14B | $1.52B | $1.05B | $1.93B | |
| Income Tax | $208M | $206M | $190M | $168M | $100M | $175M | $229M | $159M | $176M | $183M | $111M | $207M | $222M | $283M | $-304M | $359M | |
| Net Income | $870M | $1.03B | $1.20B | $908M | $555M | $954M | $1.09B | $818M | $907M | $1.09B | $1.08B | $1.13B | $1.11B | $1.45B | $2.23B | $1.57B | |
| EPS (Basic) | $1.23 | $1.45 | $1.69 | $1.28 | $0.77 | $1.33 | $1.50 | $1.13 | $1.23 | $1.47 | $1.45 | $1.53 | $1.50 | $1.96 | $3.04 | $2.13 | |
| EPS (Diluted) | $1.23 | $1.45 | $1.69 | $1.27 | $0.77 | $1.32 | $1.50 | $1.12 | $1.22 | $1.45 | $1.44 | $1.51 | $1.49 | $1.94 | $2.99 | $2.10 | |
| Shares (Basic) | 705,300,000 | 707,900,000 | -1,430,800,000 | 710,700,000 | 716,500,000 | 716,300,000 | -1,470,200,000 | 723,000,000 | 737,600,000 | 740,600,000 | -1,469,600,000 | 739,400,000 | 737,300,000 | 729,400,000 | 1,300,000 | 728,500,000 | |
| Shares (Diluted) | 707,600,000 | 711,200,000 | -1,437,500,000 | 713,700,000 | 719,100,000 | 720,800,000 | -1,483,200,000 | 729,400,000 | 742,400,000 | 748,600,000 | -1,484,700,000 | 745,900,000 | 744,700,000 | 737,200,000 | 100,000 | 737,400,000 | |
| EBITDA | · | $1.34B | · | $1.15B | $760M | $1.27B | · | $958M | $1.17B | $1.31B | · | $1.44B | $1.43B | $1.79B | · | $2.02B |
Bilanço 24
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Receivables | $3.96B | $3.82B | $3.91B | $3.75B | $3.56B | $3.51B | $3.54B | $3.51B | $3.30B | $3.38B | · | $4.20B | $4.20B | $4.31B | · | $4.41B | |
| Inventory | $3.26B | $2.61B | $2.49B | $2.67B | $2.69B | $2.53B | $2.33B | $2.68B | $2.67B | $2.65B | · | $3.02B | $3.18B | $3.38B | · | $3.24B | |
| Prepaid Expense | $1.81B | $1.81B | $1.74B | $1.65B | $1.79B | $1.49B | $1.55B | $1.25B | $1.27B | $1.32B | · | $1.70B | $1.50B | $1.46B | · | $1.46B | |
| Current Assets | $13.38B | $13.94B | $12.76B | $9.61B | $11.00B | $9.53B | $9.50B | $10.06B | $9.61B | $14.37B | · | $21.20B | $17.46B | $16.53B | · | $14.25B | |
| PP&E (Net) | $5.83B | $5.47B | $5.53B | $5.38B | $5.31B | $5.11B | $4.99B | $4.84B | $4.64B | $4.56B | $4.55B | $4.30B | $4.18B | $4.07B | $3.71B | $3.72B | |
| PP&E (Gross) | · | · | $10.30B | · | · | · | $9.09B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | $4.92B | $4.83B | $4.77B | $4.67B | $4.56B | $4.31B | $4.10B | $4.20B | $4.05B | $3.96B | · | $4.12B | $4.12B | $4.02B | · | $3.63B | |
| Goodwill | $47.41B | $42.77B | $43.15B | $42.95B | $42.99B | $41.66B | $40.50B | $42.17B | $40.80B | $40.85B | $41.61B | $39.16B | $39.58B | $39.86B | $37.28B | $38.25B | |
| Intangibles | $21.36B | $17.17B | $17.82B | $18.10B | $18.63B | $18.89B | $18.57B | $19.85B | $19.55B | $19.89B | · | $18.79B | $19.32B | $19.98B | · | $19.96B | |
| Other Non-current Assets | $4.39B | $4.21B | $4.21B | $3.87B | $3.69B | $3.94B | $3.99B | $3.69B | $3.95B | $3.73B | · | $4.29B | $4.37B | $4.61B | · | $4.85B | |
| Total Assets | $92.37B | $83.54B | $83.46B | $79.90B | $81.62B | $79.12B | $77.54B | $80.61B | $78.56B | $83.40B | $84.49B | $87.73B | $84.90B | $85.04B | $84.35B | $81.03B | |
| Accrued Liabilities | $4.87B | $4.75B | $4.96B | $4.60B | $4.57B | $4.42B | $4.54B | $4.54B | $4.36B | $4.35B | · | $4.93B | $4.86B | $5.08B | · | $5.11B | |
| Current Liabilities | $8.11B | $7.46B | $6.81B | $6.32B | $6.79B | $6.64B | $6.80B | $7.34B | $6.70B | $7.78B | · | $9.37B | $8.40B | $8.73B | · | $8.00B | |
| Capital Leases | · | · | $1.08B | · | · | · | $968M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $6.52B | $5.57B | $5.70B | $5.66B | $5.63B | $5.64B | $5.69B | $5.65B | $5.64B | $5.76B | · | $6.44B | $6.49B | $6.56B | · | $7.49B | |
| Long-term Debt | $26.56B | $18.48B | $18.42B | $16.86B | $17.36B | $16.48B | $16.00B | $17.52B | $17.01B | $18.16B | · | $22.06B | $19.88B | $19.83B | · | $19.25B | |
| Total Debt | · | $17.56B | · | $16.83B | $16.85B | $15.98B | · | $16.32B | $16.31B | $16.42B | · | $19.51B | $18.29B | $18.26B | · | $18.54B | |
| Common Stock | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | · | $9M | $9M | $9M | · | $9M | |
| Retained Earnings | $48.23B | $47.64B | $46.89B | $45.92B | $45.24B | $44.91B | $44.19B | $43.30B | $42.67B | $41.96B | · | $42.27B | $41.34B | $40.44B | · | $37.18B | |
| Treasury Stock | $12.32B | $11.41B | $11.35B | $11.34B | $9.30B | $9.31B | $8.16B | · | · | · | · | · | · | · | · | · | |
| AOCI | $-795M | $-593M | $-207M | $-590M | $-569M | $-1.61B | $-3.22B | $-1.31B | $-2.59B | $-2.74B | · | $-3.96B | $-3.58B | $-2.77B | $-2.87B | $-3.85B | |
| Stockholders' Equity | $52.58B | $52.95B | $52.53B | $51.07B | $52.33B | $50.85B | $49.54B | $51.30B | $49.90B | $53.44B | · | $52.41B | $51.72B | $51.48B | · | $46.98B | |
| Liabilities + Equity | $92.37B | $83.54B | $83.46B | $79.90B | $81.62B | $79.12B | $77.54B | $80.61B | $78.56B | $83.40B | · | $87.73B | $84.90B | $85.04B | · | $81.03B | |
| Shares Outstanding | 702,900,000 | 707,700,000 | 706,900,000 | 706,300,000 | 715,900,000 | 715,600,000 | 719,100,000 | 722,200,000 | 724,000,000 | 740,600,000 | · | 738,900,000 | 738,200,000 | 729,200,000 | · | 727,900,000 |
Nakit Akışı 13
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $93M | $58M | $63M | $83M | $91M | $61M | $57M | $84M | $87M | $60M | $61M | $57M | $87M | $70M | $25M | $89M | |
| Amort. of Intangibles | $463M | $434M | $428M | $433M | $426M | $410M | $408M | $414M | $402M | $407M | $380M | $343M | $360M | $372M | $314M | $361M | |
| Operating Cash Flow | $1.53B | $1.32B | $2.12B | $1.66B | $1.34B | $1.30B | $2.02B | $1.51B | $1.42B | $1.74B | $1.62B | $1.67B | $1.93B | $1.95B | $2.54B | $2.01B | |
| CapEx | $269M | $237M | $371M | $292M | $248M | $245M | $516M | $298M | $287M | $291M | $434M | $333M | $320M | $266M | $295M | $277M | |
| Investing Cash Flow | $-10.15B | $-249M | $-384M | $-312M | $-258M | $-242M | $-694M | $-606M | $-360M | $-321M | $-6.02B | $-329M | $-431M | $-304M | $-816M | $-515M | |
| Stock Repurchased | $894M | $0 | $0 | $2.01B | $0 | $1.08B | $809M | $640M | $4.53B | $0 | $0 | $0 | · | · | · | · | |
| Net Stock Activity | · | $0 | · | · | · | $-1.08B | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid | $283M | $226M | $226M | $229M | $229M | $194M | $195M | $196M | $200M | $177M | $200M | $199M | $218M | $204M | $203M | $204M | |
| Financing Cash Flow | $7.27B | $46M | $1.32B | $-2.78B | $-247M | $-1.25B | $-1.69B | $-845M | $-5.71B | $-133M | $-2.25B | $2.44B | $-208M | $-262M | $-906M | $-230M | |
| Net Change in Cash | $-1.35B | $1.09B | $3.09B | $-1.43B | $964M | $-85M | $-549M | $253M | $-4.66B | $1.17B | $-6.41B | $3.70B | $1.20B | $1.38B | $845M | $1.17B | |
| Taxes Paid | $350M | $191M | $392M | $277M | $330M | $201M | $367M | $315M | $396M | $222M | $630M | $476M | $466M | $228M | $706M | $469M | |
| Free Cash Flow | · | $1.08B | · | · | · | $1.05B | · | · | · | $1.45B | · | · | · | $1.67B | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $1.39B | · | · | · | $1.62B | · | · |
Kârlılık 8
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | 60.3% | · | 58.2% | 59.4% | 61.2% | · | 58.7% | 59.7% | 60.2% | · | 58.2% | 56.5% | 61.0% | · | 59.8% | |
| Operating Margin | · | 22.6% | · | 19.1% | 12.8% | 22.2% | · | 16.5% | 20.3% | 22.6% | · | 20.9% | 20.0% | 25.0% | · | 26.3% | |
| Net Margin | 13.9% | 17.3% | · | 15.0% | 9.3% | 16.6% | · | 14.1% | 15.8% | 18.8% | · | 16.4% | 15.4% | 20.2% | · | 20.5% | |
| Pretax Margin | 17.2% | 20.8% | · | 17.8% | 11.0% | 19.7% | · | 16.9% | 18.9% | 21.9% | · | 20.3% | 19.4% | 25.1% | · | 25.2% | |
| EBITDA Margin | 18.0% | 22.6% | · | 19.1% | 12.8% | 22.2% | · | 16.5% | 20.3% | 22.6% | · | 20.9% | 20.0% | 25.0% | · | 26.3% | |
| ROA | 1.0% | 1.3% | · | 1.1% | 0.69% | 1.2% | · | 0.97% | 1.1% | 1.3% | · | 1.3% | 1.3% | 1.7% | · | 1.9% | |
| ROE | 1.7% | 2.0% | · | 1.8% | 1.1% | 1.8% | · | 1.6% | 1.8% | 2.1% | · | 2.3% | 2.2% | 3.0% | · | 3.5% | |
| ROIC | 1.2% | 1.6% | · | 1.4% | 0.93% | 1.6% | · | 1.2% | 1.5% | 1.6% | · | 1.6% | 1.6% | 2.1% | · | 2.5% |
Likidite ve Solventlik 5
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.9 | · | 1.5 | 1.6 | 1.4 | · | 1.4 | 1.4 | 1.8 | · | 2.3 | 2.1 | 1.9 | · | 1.8 | |
| Quick Ratio | 0.5 | 0.5 | · | 0.6 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.4 | · | 0.4 | 0.5 | 0.5 | · | 0.6 | |
| Debt / Equity | 0.5 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | |
| LT Debt / Equity | 0.5 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 20.2 | · | 19.7 | 21.3 | 26.4 | · | 48.0 |
Verimlilik 3
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.9 | 0.9 | · | 0.9 | 0.9 | 0.9 | · | 0.8 | 0.8 | 0.8 | · | 0.9 | 1.0 | 0.9 | · | 1.2 | |
| Receivables Turnover | · | 1.6 | · | 1.7 | 1.7 | 1.7 | · | 1.5 | 1.5 | 1.5 | · | 1.6 | 1.6 | 1.6 | · | 1.8 |
Değerleme (TTM) 10
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $24.20B | $23.68B | · | $23.53B | $23.22B | $23.08B | · | $23.74B | $23.57B | $23.74B | · | $24.62B | $25.45B | $26.07B | · | $26.74B | |
| Net Income TTM | $3.36B | $3.45B | · | $3.23B | $3.23B | $3.77B | · | $3.94B | $4.23B | $4.77B | · | $5.26B | $5.81B | $6.43B | · | $6.13B | |
| Market Cap | $137.90B | $128.46B | · | $130.55B | $142.32B | $147.31B | · | $198.92B | $180.89B | $184.94B | · | $162.52B | $157.06B | $162.93B | · | $166.67B | |
| P/E | 41.6 | 37.7 | · | 41.3 | 44.9 | 40.3 | · | 52.6 | 44.4 | 42.3 | · | 27.7 | 25.0 | 24.1 | · | 27.9 | |
| P/S | 5.7 | 5.4 | · | 5.5 | 6.1 | 6.4 | · | 8.4 | 7.7 | 7.8 | · | 6.6 | 6.2 | 6.3 | · | 6.2 | |
| P/B | 2.6 | 2.4 | · | 2.6 | 2.7 | 2.9 | · | 3.9 | 3.6 | 3.5 | · | 3.1 | 3.0 | 3.2 | · | 3.5 | |
| P / Cash Flow | · | 97.2 | · | · | · | 113.4 | · | · | · | 106.3 | · | · | · | 83.7 | · | · | |
| P / FCF | · | 118.4 | · | · | · | 139.8 | · | · | · | 127.7 | · | · | · | 97.4 | · | · | |
| Earnings Yield | 2.4% | 2.6% | · | 2.4% | 2.2% | 2.5% | · | 1.9% | 2.2% | 2.4% | · | 3.6% | 4.0% | 4.2% | · | 3.6% | |
| Payout Ratio | · | 22.0% | · | · | · | 20.3% | · | · | · | 16.3% | · | · | · | 14.1% | · | · |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Gelir | $24.57B | $23.88B | $23.89B | $26.64B | $24.80B |
| Brüt Kâr Marjı % | 59.1% | 59.5% | 58.7% | 60.2% | 61.0% |
| Faaliyet Kâr Marjı % | 19.1% | 20.4% | 21.8% | 27.6% | 25.4% |
| Net Gelir | $3.61B | $3.90B | $4.76B | $7.21B | $6.43B |
| Seyreltilmiş Hisse Başı Kâr | $5.05 | $5.29 | $6.38 | $9.66 | $8.61 |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | 0.4 | 0.3 | 0.3 | 0.4 | 0.5 |
| Cari Oran | 1.9 | 1.4 | 1.7 | 1.9 | 1.4 |
| Cari Oran | 0.6 | 0.5 | 0.5 | 0.6 | 0.6 |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $5.26B | $5.30B | $5.78B | $7.37B | $7.06B |
Son Haberler Bu şirketten bahseden son manşetler
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kurumsal Sahipler (13F) 2.341 dosya · $71.5B toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 157 (-46 önceki Ç'ye göre) | 181 (-73 önceki Ç'ye göre) | 676 (-90 önceki Ç'ye göre) | 984 (+58 önceki Ç'ye göre) | +16.5M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $7.881.505.437 | 41.377.076 | 11,02% | Hisse senetleri |
| STATE STREET CORP | $5.431.565.288 | 28.456.019 | 7,60% | Hisse senetleri |
| FMR LLC | $3.977.715.242 | 20.882.587 | 5,56% | Hisse senetleri |
| WELLINGTON MANAGEMENT GROUP LLP | $3.015.682.979 | 15.832.019 | 4,22% | Hisse senetleri |
| Capital International Investors | $2.953.960.497 | 15.504.420 | 4,13% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.705.808.973 | 14.205.213 | 3,78% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $2.313.841.539 | 12.214.999 | 3,24% | Hisse senetleri |
| Capital Research Global Investors | $2.060.650.455 | 10.818.030 | 2,88% | Hisse senetleri |
| NORGES BANK | $1.816.780.335 | 9.537.906 | 2,54% | Hisse senetleri |
| EAGLE CAPITAL MANAGEMENT LLC | $1.783.176.557 | 9.361.490 | 2,49% | Hisse senetleri |
| GENERATION INVESTMENT MANAGEMENT LLP | $1.287.948.806 | 6.761.596 | 1,80% | Hisse senetleri |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $983.459.478 | 5.163.059 | 1,38% | Hisse senetleri |
| Fisher Asset Management, LLC | $854.260.080 | 4.484.774 | 1,19% | Hisse senetleri |
| FLOSSBACH VON STORCH SE | $747.259.707 | 3.923.035 | 1,05% | Hisse senetleri |
| PARNASSUS INVESTMENTS, LLC | $699.862.950 | 3.674.207 | 0,98% | Hisse senetleri |
| Holocene Advisors, LP | $684.356.163 | 3.592.798 | 0,96% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $674.795.972 | 3.542.608 | 0,94% | Hisse senetleri |
| D1 Capital Partners L.P. | $434.682.789 | 2.282.039 | 0,61% | Hisse senetleri |
| FIRST MANHATTAN CO. LLC. | $429.106.102 | 2.248.424 | 0,60% | Hisse senetleri |
| BlackRock, Inc. | $424.712.304 | 2.229.695 | 0,59% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $423.080.600 | 2.221.129 | 0,59% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $412.955.174 | 2.167.971 | 0,58% | Hisse senetleri |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $410.455.346 | 2.154.842 | 0,57% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $407.739.012 | 2.140.587 | 0,57% | Hisse senetleri |
| Castle Hook Partners LP | $404.836.478 | 2.125.349 | 0,57% | Hisse senetleri |
| AMERIPRISE FINANCIAL INC | $392.617.529 | 2.061.025 | 0,55% | Hisse senetleri |
| CANADA PENSION PLAN INVESTMENT BOARD | $389.240.356 | 2.043.471 | 0,54% | Hisse senetleri |
| 1832 Asset Management L.P. | $364.584.815 | 1.914.032 | 0,51% | Hisse senetleri |
| PRIMECAP MANAGEMENT CO/CA/ | $359.830.054 | 1.889.070 | 0,50% | Hisse senetleri |
| LAZARD ASSET MANAGEMENT LLC | $355.388.763 | 1.865.754 | 0,50% | Hisse senetleri |
| Swiss National Bank | $342.198.844 | 1.796.508 | 0,48% | Hisse senetleri |
| Sumitomo Mitsui Trust Group, Inc. | $341.443.781 | 1.792.544 | 0,48% | Hisse senetleri |
| NEUBERGER BERMAN GROUP LLC | $339.224.793 | 1.780.339 | 0,47% | Hisse senetleri |
| LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA | $318.260.440 | 1.670.835 | 0,45% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $301.393.888 | 1.582.286 | 0,42% | Hisse senetleri |
| Legal & General Group Plc | $295.737.157 | 1.552.589 | 0,41% | Hisse senetleri |
| Mitsubishi UFJ Asset Management Co., Ltd. | $295.010.472 | 1.548.774 | 0,41% | Hisse senetleri |
| FIL Ltd | $290.578.764 | 1.525.508 | 0,41% | Hisse senetleri |
| National Pension Service | $285.900.766 | 1.500.949 | 0,40% | Hisse senetleri |
| VAN ECK ASSOCIATES CORP | $281.058.192 | 1.475.526 | 0,39% | Hisse senetleri |
| Southpoint Capital Advisors LP | $266.672.000 | 1.400.000 | 0,37% | Hisse senetleri |
| BNP PARIBAS FINANCIAL MARKETS | $263.806.038 | 1.384.954 | 0,37% | Hisse senetleri |
| Anomaly Capital Management, LP | $260.066.154 | 1.365.320 | 0,36% | Hisse senetleri |
| Vanguard Global Advisers, LLC | $258.865.177 | 1.359.015 | 0,36% | Hisse senetleri |
| RAYMOND JAMES FINANCIAL INC | $257.409.127 | 1.351.371 | 0,36% | Hisse senetleri |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $246.675.000 | 1.295.020 | 0,35% | Hisse senetleri |
| ENVESTNET ASSET MANAGEMENT INC | $241.732.034 | 1.269.068 | 0,34% | Hisse senetleri |
| Sustainable Growth Advisers, LP | $239.075.067 | 1.255.119 | 0,33% | Hisse senetleri |
| AVIVA PLC | $237.495.036 | 1.246.824 | 0,33% | Hisse senetleri |
| California Public Employees Retirement System | $235.582.426 | 1.236.783 | 0,33% | Hisse senetleri |
| VANGUARD ASSET MANAGEMENT, Ltd | $232.825.990 | 1.222.312 | 0,33% | Hisse senetleri |
| UBS Group AG | $222.739.883 | 1.169.361 | 0,31% | Hisse senetleri |
| GLENVIEW CAPITAL MANAGEMENT, LLC | $218.286.080 | 1.145.979 | 0,31% | Hisse senetleri |
| Nuveen, LLC | $214.912.083 | 1.128.266 | 0,30% | Hisse senetleri |
| PRUDENTIAL FINANCIAL INC | $213.476.650 | 1.120.730 | 0,30% | Hisse senetleri |
| KING LUTHER CAPITAL MANAGEMENT CORP | $206.309.650 | 1.083.104 | 0,29% | Hisse senetleri |
| MONTRUSCO BOLTON INVESTMENTS INC. | $202.781.580 | 1.064.582 | 0,28% | Hisse senetleri |
| MACKENZIE FINANCIAL CORP | $198.886.263 | 1.044.132 | 0,28% | Hisse senetleri |
| ROYAL LONDON ASSET MANAGEMENT LTD | $191.867.454 | 1.007.284 | 0,27% | Hisse senetleri |
| Mirova US LLC | $190.479.238 | 999.996 | 0,27% | Hisse senetleri |
| RHUMBLINE ADVISERS | $189.703.347 | 995.923 | 0,27% | Hisse senetleri |
| BLAIR WILLIAM & CO/IL | $184.974.108 | 971.095 | 0,26% | Hisse senetleri |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $184.610.866 | 973.686 | 0,26% | Hisse senetleri |
| CITADEL ADVISORS LLC | $179.754.833 | 943.694 | 0,25% | Hisse senetleri |
| BARCLAYS PLC | $173.566.710 | 911.207 | 0,24% | Hisse senetleri |
| Qube Research & Technologies Ltd | $160.863.027 | 844.514 | 0,22% | Hisse senetleri |
| JONES FINANCIAL COMPANIES LLLP | $158.843.698 | 809.642 | 0,22% | Hisse senetleri |
| JANE STREET GROUP, LLC | $157.469.816 | 826.700 | 0,22% | Alım opsiyonu |
| Unisphere Establishment | $154.098.320 | 809.000 | 0,22% | Hisse senetleri |
| RENAISSANCE TECHNOLOGIES LLC | $144.885.945 | 760.636 | 0,20% | Hisse senetleri |
| Balyasny Asset Management L.P. | $144.613.749 | 759.207 | 0,20% | Hisse senetleri |
| CI INVESTMENTS INC. | $143.569.157 | 753.723 | 0,20% | Hisse senetleri |
| Focus Partners Wealth | $138.144.377 | 725.093 | 0,19% | Hisse senetleri |
| Corient Private Wealth LP | $134.474.841 | 705.975 | 0,19% | Hisse senetleri |
| Squarepoint Ops LLC | $133.894.678 | 702.933 | 0,19% | Hisse senetleri |
| NEW YORK STATE COMMON RETIREMENT FUND | $131.380.532 | 689.734 | 0,18% | Hisse senetleri |
| DAVENPORT & Co LLC | $129.567.583 | 678.343 | 0,18% | Hisse senetleri |
| JUPITER ASSET MANAGEMENT LTD | $128.724.672 | 672.386 | 0,18% | Hisse senetleri |
| JOHNSON INVESTMENT COUNSEL INC | $124.418.228 | 653.183 | 0,17% | Hisse senetleri |
| Alecta Tjanstepension Omsesidigt | $123.111.539 | 646.900 | 0,17% | Hisse senetleri |
| Dorsey Asset Management, LLC | $119.280.671 | 626.211 | 0,17% | Hisse senetleri |
| Pictet Asset Management Holding SA | $119.219.547 | 625.690 | 0,17% | Hisse senetleri |
| Aberdeen Group plc | $118.872.663 | 624.069 | 0,17% | Hisse senetleri |
| FRANKLIN RESOURCES INC | $116.674.905 | 612.531 | 0,16% | Hisse senetleri |
| ALLIANCEBERNSTEIN L.P. | $114.452.230 | 603.651 | 0,16% | Hisse senetleri |
| Welch & Forbes LLC | $113.968.746 | 598.324 | 0,16% | Hisse senetleri |
| JENNISON ASSOCIATES LLC | $113.865.135 | 597.780 | 0,16% | Hisse senetleri |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $112.932.032 | 589.589 | 0,16% | Hisse senetleri |
| BRADLEY FOSTER & SARGENT INC/CT | $111.570.652 | 585.734 | 0,16% | Hisse senetleri |
| JARISLOWSKY, FRASER Ltd | $109.881.639 | 554.230 | 0,15% | Hisse senetleri |
| First Pacific Advisors, LP | $107.579.485 | 564.781 | 0,15% | Hisse senetleri |
| Woodline Partners LP | $107.477.769 | 564.247 | 0,15% | Hisse senetleri |
| EMINENCE CAPITAL, LP | $106.409.966 | 561.234 | 0,15% | Hisse senetleri |
| Canoe Financial LP | $106.328.603 | 558.214 | 0,15% | Hisse senetleri |
| Mariner, LLC | $105.627.587 | 554.431 | 0,15% | Hisse senetleri |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $105.203.437 | 552.307 | 0,15% | Hisse senetleri |
| Third Point LLC | $102.859.200 | 540.000 | 0,14% | Hisse senetleri |
| Meridiem Capital Partners LP | $102.371.000 | 537.437 | 0,14% | Hisse senetleri |
| Spear Holdings RSC Ltd | $101.874.609 | 534.831 | 0,14% | Hisse senetleri |
| PBCay One RSC Ltd | $101.868.133 | 534.797 | 0,14% | Hisse senetleri |
Şirket yöneticileri 51 içeriden öğrenenler · 24 yöneticiler · 12 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Rainer Blair | President & CEO | 01 Mart 2026 A | 37.988 | 0 | 0 | $0 |
| Thomas Patrick Joyce JR | President and CEO | 24 Temmuz 2020 M | 203.513 | 0 | 0 | $0 |
| Lawrence H Culp JR | President and CEO | 18 Temmuz 2014 M | 512.199 | 0 | 0 | $0 |
| Georgeann Couchara | SVP, Human Resources | 15 Mayıs 2026 F | 8.291 | 0 | 2 | $-1.088.686 |
| Matthew Mcgrew | Executive Vice President | 01 Mart 2026 A | 26.825 | 0 | 1 | $-3.470.835 |
| Bradley R Gray | SVP Strategic Development | 01 Mart 2026 A | 14.463 | 0 | 0 | $0 |
| Brian W Ellis | Senior Vice President | 04 Şubat 2026 A | 14.994 | 0 | 2 | $-4.773.810 |
| Daniel Raskas | SVP - Corporate Development | 01 Şubat 2025 A | 10.524 | 0 | 0 | $0 |
| William King | SVP, Strategic Development | 15 Mayıs 2024 M | 48.190 | 0 | 0 | $0 |
| Joakim Weidemanis | Executive Vice President | 15 Mayıs 2024 F | 87.333 | 0 | 0 | $0 |
| Jennifer Honeycutt | Executive Vice President | 15 Mayıs 2023 F | 26.165 | 0 | 0 | $0 |
| Angela S Lalor | SVP, Human Resources | 24 Şubat 2022 A | 47.962 | 0 | 0 | $0 |
| Robert S Lutz | SVP-Chief Accounting Officer | 21 Mayıs 2021 S | 16.155 | 0 | 0 | $0 |
| William K Daniel | EVP | 20 Şubat 2020 A | 109.886 | 0 | 0 | $0 |
| James A Lico | Executive Vice President | 10 Mayıs 2016 A | 113.198 | 0 | 0 | $0 |
| Mark A Beck | Executive Vice President | 28 Temmuz 2015 S | 0 | 0 | 0 | $0 |
| Jonathan P Graham | Senior VP & GC | 19 Mayıs 2015 M | 34.606 | 0 | 0 | $0 |
| James H Ditkoff | Senior VP-Finance & Tax | 21 Şubat 2015 F | 174.406 | 0 | 0 | $0 |
| Philip Knisely | Executive Vice President | 29 Ocak 2010 A | 5.010 | 0 | 0 | $0 |
| Steve Simms | Executive Vice President | 26 Ekim 2007 A | 4.400 | 0 | 0 | $0 |
| Patrick W Allender | Executive VP | 01 Şubat 2007 M | 75.813 | 0 | 0 | $0 |
| Daniel A Pryor | VP-Strategic Development | 04 Mayıs 2005 A | 0 | 0 | 0 | $0 |
| Donald E Doles | VP-Danaher Business System | 31 Ağustos 2004 A | — | 0 | 0 | $0 |
| Chris Mcmahon | VP -- Controller | 01 Ocak 2004 A | 0 | 0 | 0 | $0 |
| Charles W Lamanna | Yönetim kurulu üyesi | 15 Mayıs 2026 A | 1.359 | 0 | 0 | $0 |
| John T Schwieters | Yönetim kurulu üyesi | 15 Temmuz 2025 M | 19.815 | 0 | 0 | $0 |
| Jessica L Mega | Yönetim kurulu üyesi | 15 Mayıs 2025 A | 3.302 | 0 | 0 | $0 |
| Pardis C Sabeti | Yönetim kurulu üyesi | 25 Ekim 2024 A | 5.283 | 0 | 0 | $0 |
| Walter G Lohr | Yönetim kurulu üyesi | 15 Şubat 2024 M | 14.129 | 0 | 0 | $0 |
| Donald J Ehrlich | Yönetim kurulu üyesi | 10 Şubat 2020 M | 123.203 | 0 | 0 | $0 |
| Robert J Hugin | Yönetim kurulu üyesi | 15 Mayıs 2017 A | 3.576 | 0 | 0 | $0 |
| Mortimer M Caplin | Yönetim kurulu üyesi | 26 Nisan 2013 A | 83.213 | 0 | 0 | $0 |
| Emmet A Stephenson JR | Yönetim kurulu üyesi | 30 Kasım 2007 M | 368.240 | 0 | 0 | $0 |
| DANAHER CORP /DE/ | 10% sahip | 30 Eylül 2023 J | 0 | 0 | 0 | $0 |
| Matthew E Gugino | — | 04 Ağustos 2026 A | 11.401 | 0 | 0 | $0 |
| Gregory M Milosevich | — | 04 Ağustos 2026 A | 24.467 | 0 | 1 | $-274.573 |
| Montgomery Julie A Sawyer | — | 04 Ağustos 2026 A | 22.221 | 0 | 0 | $0 |
| Christopher Paul Riley | — | 04 Ağustos 2026 A | 61.472 | 0 | 0 | $0 |
| Christopher Bouda | — | 04 Ağustos 2026 A | 9.107 | 0 | 0 | $0 |
| Jose-Carlos Gutierrez-Ramos | — | 04 Ağustos 2026 A | 32.495 | 0 | 0 | $0 |
| Jonathan Leiken | — | 04 Ağustos 2026 A | 12.546 | 0 | 0 | $0 |
| Mitchell P. Rales | — | 04 Ağustos 2026 A | 553.228 | 0 | 9 | $-234.561.260 |
| Steven M Rales | — | 04 Ağustos 2026 A | 3.605.808 | 0 | 0 | $0 |
| Shane A Sanders | — | 31 Temmuz 2026 A | 5.914 | 0 | 0 | $0 |
| Raymond C Stevens | — | 31 Temmuz 2026 A | 13.728 | 0 | 0 | $0 |
| Teri List-Stoll | — | 31 Temmuz 2026 A | 21.470 | 0 | 2 | $-1.333.322 |
| Feroz Dewan | — | 31 Temmuz 2026 A | 4.686 | 0 | 0 | $0 |
| Elias A. Zerhouni | — | 31 Temmuz 2026 A | 45.303 | 0 | 0 | $0 |
| Linda P Hefner | — | 31 Temmuz 2026 A | 26.829 | 0 | 0 | $0 |
| Alan G Spoon | — | 31 Temmuz 2026 A | 124.774 | 0 | 1 | $-237.202 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
Aktivistler ve %5+ sahipler 9 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Mitchell P. Rales ×9 başvurular | 02 Kasım 2021 | — | İlk başvuru | — | SEC |
| Steven M. Rales ×6 başvurular | 14 Haziran 2021 | — | İlk başvuru | — | SEC |
| Açıklanmayan raporlama kişisi | 22 Ekim 2014 | — | İlk başvuru | M&A / satış | SEC |
| Danaher Corporation., Aegean Acquisition Corp. ×2 başvurular | 09 Aralık 2010 | — | İlk başvuru | — | SEC |
| Danaher Corporation, DH Holdings Corp., DH Technologies Development Pte. Ltd. ×3 başvurular | 05 Şubat 2010 | — | İlk başvuru | — | SEC |
| Equity Group Holdings LLC, Equity Group Holdings II LLC, Steven M. Rales, Mitchell P. Rales ×6 başvurular | 30 Mart 2007 | — | İlk başvuru | — | SEC |
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 23 Nisan 2003 | — | İlk başvuru | — | SEC |
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 08 Haziran 2001 | — | İlk başvuru | — | SEC |
| Açıklanmayan raporlama kişisi | 25 Mayıs 2001 | — | İlk başvuru | M&A / satış | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF sahipliği 194 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| PRCS · Parnassus Funds II | 5,06% | 42.782 NS | 30 Haziran 2026 | N-PORT |
| FMED · Fidelity Covington Trust | 3,42% | 7.675 NS | 31 Mayıs 2026 | N-PORT |
| MBCC · Northern Lights Fund Trust IV | 3,31% | 33.421 NS | 31 Mayıs 2026 | N-PORT |
| BCHP · Principal Exchange-Traded Funds | 3,22% | 36.941 NS | 30 Haziran 2026 | N-PORT |
| HRTS · Tema ETF Trust | 2,66% | 7.557 NS | 31 Mayıs 2026 | N-PORT |
| ASLV · ALLSPRING EXCHANGE-TRADED FUNDS TRU… | 2,45% | 30.573 NS | 30 Nisan 2026 | N-PORT |
| MEDI · Harbor ETF Trust | 2,43% | 3.739 NS | 30 Nisan 2026 | N-PORT |
| YALL · Tidal Trust I | 2,29% | 12.162 NS | 31 Mayıs 2026 | N-PORT |
| FMCE · Northern Lights Fund Trust IV | 2,22% | 8.213 NS | 31 Mayıs 2026 | N-PORT |
| JXX · Janus Detroit Street Trust | 1,92% | 3.881 NS | 30 Nisan 2026 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 1,90% | 1.184 NS | 30 Nisan 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 1,84% | 293.052 NS | 30 Nisan 2026 | N-PORT |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1,68% | 5.006 NS | 30 Nisan 2026 | N-PORT |
| RXL · ProShares Trust | 1,66% | 6.560 NS | 31 Mayıs 2026 | N-PORT |
| ANEW · ProShares Trust | 1,66% | 701 NS | 31 Mayıs 2026 | N-PORT |
| CURE · Direxion Shares ETF Trust | 1,62% | 12.545 NS | 30 Nisan 2026 | N-PORT |
| FMCX · Northern Lights Fund Trust IV | 1,56% | 10.073 NS | 31 Mayıs 2026 | N-PORT |
| SAWG · ETF Series Solutions | 1,38% | 194 NS | 30 Nisan 2026 | N-PORT |
| NULV · Nushares ETF Trust | 1,26% | 146.061 NS | 30 Nisan 2026 | N-PORT |
| PSET · Principal Exchange-Traded Funds | 1,24% | 1.868 NS | 30 Haziran 2026 | N-PORT |
| GRW · TCW ETF Trust | 1,21% | 4.855 NS | 30 Nisan 2026 | N-PORT |
| PEXL · Pacer Funds Trust | 1,19% | 3.038 NS | 30 Nisan 2026 | N-PORT |
| GNOM · Global X Funds | 1,17% | 3.573 NS | 31 Mayıs 2026 | N-PORT |
| NULC · Nushares ETF Trust | 1,11% | 3.541 NS | 30 Nisan 2026 | N-PORT |
| AGRW · ALLSPRING EXCHANGE-TRADED FUNDS TRU… | 1,07% | 6.377 NS | 30 Nisan 2026 | N-PORT |
| TGLB · T. Rowe Price Exchange-Traded Funds… | 0,92% | 1.138 NS | 30 Nisan 2026 | N-PORT |
| QUVU · Hartford Funds Exchange-Traded Trust | 0,89% | 8.584 NS | 30 Nisan 2026 | N-PORT |
| ROPE · EA Series Trust | 0,88% | 408 NS | 29 Mayıs 2026 | N-PORT |
| SNPV · DBX ETF Trust | 0,78% | 9.793 NS | 29 Mayıs 2026 | N-PORT |
| WINN · Harbor ETF Trust | 0,75% | 45.913 NS | 30 Nisan 2026 | N-PORT |
| ACLC · AMERICAN CENTURY ETF TRUST | 0,75% | 12.657 NS | 31 Mayıs 2026 | N-PORT |
| BIGY · Tidal Trust II | 0,75% | 1.089 NS | 30 Nisan 2026 | N-PORT |
| PRAY · FIS Trust | 0,74% | 3.267 NS | 31 Mayıs 2026 | N-PORT |
| CGCV · Capital Group Conservative Equity E… | 0,63% | 60.285 NS | 31 Mayıs 2026 | N-PORT |
| MFSG · MFS Active Exchange Traded Funds Tr… | 0,57% | 10.794 NS | 31 Mayıs 2026 | N-PORT |
| CRTC · DBX ETF Trust | 0,55% | 3.919 NS | 31 Mayıs 2026 | N-PORT |
| JSTC · Tidal Trust I | 0,47% | 8.617 NS | 31 Mayıs 2026 | N-PORT |
| FFLC · FIDELITY COVINGTON TRUST | 0,41% | 25.937 NS | 30 Nisan 2026 | N-PORT |
| SCHG · SCHWAB STRATEGIC TRUST | 0,40% | 1.339.145 NS | 31 Mayıs 2026 | N-PORT |
| MSLC · MORGAN STANLEY PATHWAY FUNDS | 0,39% | 85.259 NS | 31 Mayıs 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 0,38% | 18.713 NS | 30 Nisan 2026 | N-PORT |
| CGGE · Capital Group Global Equity ETF | 0,36% | 54.429 NS | 31 Mayıs 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0,34% | 274.663 NS | 30 Nisan 2026 | N-PORT |
| GVUS · Goldman Sachs ETF Trust | 0,34% | 7.628 NS | 31 Mayıs 2026 | N-PORT |
| USSG · DBX ETF Trust | 0,34% | 10.531 NS | 29 Mayıs 2026 | N-PORT |
| CHRI · Global X Funds | 0,33% | 96 NS | 30 Nisan 2026 | N-PORT |
| HLAL · Listed Funds Trust | 0,33% | 16.620 NS | 31 Mayıs 2026 | N-PORT |
| SPUS · Tidal Trust I | 0,31% | 45.829 NS | 31 Mayıs 2026 | N-PORT |
| HELO · J.P. Morgan Exchange-Traded Fund Tr… | 0,31% | 68.633 NS | 30 Nisan 2026 | N-PORT |
| SNPE · DBX ETF Trust | 0,29% | 43.421 NS | 29 Mayıs 2026 | N-PORT |